FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2522952431> ?p ?o ?g. }

• W2522952431 abstract "Abstract Bleeding and thrombotic events are major clinical complications of ET, together with progression to myelofibrosis and leukemic transformation (AML). The JAK2 V617F mutation, the thrombopoietin receptor mutation MPL W515K/L and the most recently discovered calreticulin (CALR) mutations are mutually exclusive in ET, account for up to 80-90 % of ET cases and support a novel molecular categorization of ET. In a retrospective study, we have examined the clinical phenotype and outcome of a Belgian cohort of 165 ET patients in relation to their mutational status. 38% of the patients were CALR mutated, 22% and 12% of whom carried Type 1 (p.L367fs*46) and Type 2 (p.K385fs*47) indels respectively. 35% were JAK2 V617F positive, 7% were MPL W515K/L positive, one patient was positive for both CALR and JAK2 V617F mutations, and 20% were triple negative (Fig. 1). We compared the hematological and clinical features between CALR mutant patients and JAK2 V617F positive patients. This revealed that CALR mutant ET is associated with younger age than JAK2 V617F positive ET (median age 56 y (range 23-84) versus 65 y (range 36-94), p<0.001), male gender (58% versus 39%, p=0.03), higher platelet count (988 ± 367*109/L versus 870 ± 291*109/L, p=0.04 (mean ± SD)), lower leukocyte count (9.1 ± 3.2*109/L versus 11.6 ± 5.8*109/L, p<0.001), lower erythrocyte count (4.36 ± 0.9*1012/L versus 4.98 ± 0.65*1012/L, p<0.001), hemoglobin (13.2 ± 1.8 g/dL versus 14.3 ±1.6 g/dL, p=0.001) and hematocrit (40 ± 6.2 % versus 44 ± 4.6 %, p<0.001). Analysis of the CALR mutant group according to the indel type showed that CALR Type 1 deletion is strongly associated with male gender (62%). Contrary to previously published findings, we did not find significant differences between CALR type I and II mutations with regard to age and platelet count.CALR mutant patients had a better overall survival than JAK2 V617F positive patients (mean survival 28 y versus 16 y, p=0.01). However, the better overall survival for CALR mutant ET was restricted to patients less than 60 years old (mean survival 29.2 y versus 18.5 y, p=0.02) while in the age group above 60 years, the overall survival was not significantly different (mean survival 18.3 y versus 13 y, p=0.32) (Fig. 2). In our cohort, no difference in myelofibrosis-free survival or leukemia-free survival was found between the molecular subtypes, although the risk of developing myelofibrosis was unexpectedly higher in the CALR mutant group (18% versus 4%, p=0.01). In contrast to other studies, we found no difference in the frequency of arteriovenous complications. In conclusion, this study on a Belgian cohort supports the notion that CALR mutant ET is phenotypically distinct from JAK2 V617F positive ET, with regard to the clinical and hematological presentation as well as the overall survival. In this cohort, the better overall survival was most marked in ET patients less than 60 y of age. Our study adds to the growing body of evidence that CALR mutant ET is a disease entity distinct from JAK2 V617F positive ET. Figure 1 Distribution of 165 ET patients according to their mutational status. Figure 1. Distribution of 165 ET patients according to their mutational status. Figure 2 Overall survival of CALR mutant and JAK2 V617F positive groups stratified according to age: older than 60 y versus younger than or equal to 60 y. Figure 2. Overall survival of CALR mutant and JAK2 V617F positive groups stratified according to age: older than 60 y versus younger than or equal to 60 y. Disclosures No relevant conflicts of interest to declare." @default.
• W2522952431 created "2016-09-30" @default.
• W2522952431 creator A5001327898 @default.
• W2522952431 creator A5003884581 @default.
• W2522952431 creator A5009816097 @default.
• W2522952431 creator A5018514641 @default.
• W2522952431 creator A5032481849 @default.
• W2522952431 creator A5074370360 @default.
• W2522952431 creator A5076133249 @default.
• W2522952431 creator A5079520283 @default.
• W2522952431 creator A5091536542 @default.
• W2522952431 date "2014-12-06" @default.
• W2522952431 modified "2023-09-28" @default.
• W2522952431 title "Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia" @default.
• W2522952431 doi "https://doi.org/10.1182/blood.v124.21.5584.5584" @default.
• W2522952431 hasPublicationYear "2014" @default.
• W2522952431 type Work @default.
• W2522952431 sameAs 2522952431 @default.
• W2522952431 citedByCount "0" @default.
• W2522952431 crossrefType "journal-article" @default.
• W2522952431 hasAuthorship W2522952431A5001327898 @default.
• W2522952431 hasAuthorship W2522952431A5003884581 @default.
• W2522952431 hasAuthorship W2522952431A5009816097 @default.
• W2522952431 hasAuthorship W2522952431A5018514641 @default.
• W2522952431 hasAuthorship W2522952431A5032481849 @default.
• W2522952431 hasAuthorship W2522952431A5074370360 @default.
• W2522952431 hasAuthorship W2522952431A5076133249 @default.
• W2522952431 hasAuthorship W2522952431A5079520283 @default.
• W2522952431 hasAuthorship W2522952431A5091536542 @default.
• W2522952431 hasConcept C104317684 @default.
• W2522952431 hasConcept C126322002 @default.
• W2522952431 hasConcept C127716648 @default.
• W2522952431 hasConcept C135763542 @default.
• W2522952431 hasConcept C143998085 @default.
• W2522952431 hasConcept C158617107 @default.
• W2522952431 hasConcept C2778837598 @default.
• W2522952431 hasConcept C2780007613 @default.
• W2522952431 hasConcept C2780076729 @default.
• W2522952431 hasConcept C2781057849 @default.
• W2522952431 hasConcept C2909272587 @default.
• W2522952431 hasConcept C47450691 @default.
• W2522952431 hasConcept C54355233 @default.
• W2522952431 hasConcept C71924100 @default.
• W2522952431 hasConcept C72563966 @default.
• W2522952431 hasConcept C86803240 @default.
• W2522952431 hasConcept C90924648 @default.
• W2522952431 hasConceptScore W2522952431C104317684 @default.
• W2522952431 hasConceptScore W2522952431C126322002 @default.
• W2522952431 hasConceptScore W2522952431C127716648 @default.
• W2522952431 hasConceptScore W2522952431C135763542 @default.
• W2522952431 hasConceptScore W2522952431C143998085 @default.
• W2522952431 hasConceptScore W2522952431C158617107 @default.
• W2522952431 hasConceptScore W2522952431C2778837598 @default.
• W2522952431 hasConceptScore W2522952431C2780007613 @default.
• W2522952431 hasConceptScore W2522952431C2780076729 @default.
• W2522952431 hasConceptScore W2522952431C2781057849 @default.
• W2522952431 hasConceptScore W2522952431C2909272587 @default.
• W2522952431 hasConceptScore W2522952431C47450691 @default.
• W2522952431 hasConceptScore W2522952431C54355233 @default.
• W2522952431 hasConceptScore W2522952431C71924100 @default.
• W2522952431 hasConceptScore W2522952431C72563966 @default.
• W2522952431 hasConceptScore W2522952431C86803240 @default.
• W2522952431 hasConceptScore W2522952431C90924648 @default.
• W2522952431 hasLocation W25229524311 @default.
• W2522952431 hasOpenAccess W2522952431 @default.
• W2522952431 hasPrimaryLocation W25229524311 @default.
• W2522952431 hasRelatedWork W2084050646 @default.
• W2522952431 hasRelatedWork W2085253297 @default.
• W2522952431 hasRelatedWork W2111452003 @default.
• W2522952431 hasRelatedWork W2135192688 @default.
• W2522952431 hasRelatedWork W2190290769 @default.
• W2522952431 hasRelatedWork W2195257611 @default.
• W2522952431 hasRelatedWork W2306249148 @default.
• W2522952431 hasRelatedWork W2418543576 @default.
• W2522952431 hasRelatedWork W2521154807 @default.
• W2522952431 hasRelatedWork W2582196192 @default.
• W2522952431 hasRelatedWork W2588316106 @default.
• W2522952431 hasRelatedWork W2589531826 @default.
• W2522952431 hasRelatedWork W2589657471 @default.
• W2522952431 hasRelatedWork W2607107375 @default.
• W2522952431 hasRelatedWork W2782202435 @default.
• W2522952431 hasRelatedWork W2790700955 @default.
• W2522952431 hasRelatedWork W2958925567 @default.
• W2522952431 hasRelatedWork W2976472220 @default.
• W2522952431 hasRelatedWork W2979479321 @default.
• W2522952431 hasRelatedWork W2994065526 @default.
• W2522952431 isParatext "false" @default.
• W2522952431 isRetracted "false" @default.
• W2522952431 magId "2522952431" @default.
• W2522952431 workType "article" @default.